Can severe iron deficiency worsen fatigue and exercise tolerance?

Iron deficiency is a primary driver of reduced physical capacity, particularly in females where blood loss—such as through menstruation—is a common risk factor. In severe cases, the resulting depletion of hemoglobin levels leads to a cascade of physiological impairments that impact daily functioning and athletic performance.

Clinical evidence

Research, including meta-analyses of randomized controlled trials (RCTs), confirms that iron deficiency significantly increases subjective fatigue in women with low ferritin levels (typically ≤50 μg/L). This effect persists even before the onset of clinical anemia. In active populations, iron deficiency is associated with a 3%–4% reduction in maximal aerobic capacity (VO2 max) and endurance. Targeted iron replacement therapy has demonstrated the ability to reverse these deficits, with some studies showing improvements in endurance performance of up to 20% following supplementation.

Mechanistic foundations

The physiological link between low hemoglobin and exercise intolerance is rooted in the dynamics of systemic oxygen delivery (DO2). Hemoglobin serves as the primary vehicle for transport, binding approximately 98% of arterial oxygen; only a negligible fraction is dissolved in plasma. Consequently, a reduction in hemoglobin concentration (anemia) results in a linear decline in arterial oxygen content (CaO2).

While the body attempts to maintain tissue oxygenation through compensatory increases in cardiac output and the oxygen extraction ratio (OER), these mechanisms have physiological limits. When hemoglobin levels fall below critical thresholds, oxygen delivery can no longer meet the metabolic demands of muscles and organs. This leads to tissue hypoxia and impaired mitochondrial function, which manifests clinically as fatigue and a rapid decline in exercise tolerance.

Bottom line

Severe iron deficiency reduces hemoglobin levels, directly compromising the blood's oxygen-carrying capacity and systemic oxygen delivery. This deficit leads to measurable increases in fatigue and significant reductions in exercise tolerance, though these symptoms are generally reversible through appropriate iron replacement therapy.